Browse > Article
http://dx.doi.org/10.14401/KASMED.2015.22.1.25

Association between Antipsychotic-Induced Restless Legs Syndrome and Glutathione S-Transferase Gst-M1, Gst-T1 and Gst-P1 Gene Polymorphisms  

Kang, Seung-Gul (Department of Psychiatry, Gil Medical Center, Gachon University, School of Medicine)
Park, Young-Min (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Kim, Leen (Department of Psychiatry, Korea University College of Medicine)
Lee, Heon-Jeong (Department of Psychiatry, Korea University College of Medicine)
Publication Information
Sleep Medicine and Psychophysiology / v.22, no.1, 2015 , pp. 25-29 More about this Journal
Abstract
Objectives: The pathophysiology of restless legs syndrome (RLS) has not been fully elucidated. Oxidative stress might play a role in the development of RLS and other antipsychotic-induced side effects such as tardive dyskinesia. In the present study, we investigated whether the glutathione S-transferase (GST) gene polymorphisms are associated with antipsychotic-induced RLS in schizophrenia. Methods: We assessed antipsychotic-induced RLS symptoms in 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group. The GST-M1, GST-T1 and GST-P1 loci were analyzed using PCR-based methods. Results: We divided the subjects into 2 groups: those with RLS symptoms (n = 96) and those without RLS symptoms (n = 94). There were no significant differences in the distributions of the GST-M1 genotypes (${\chi}^2=3.56$, p = 0.059), GST-T1 (${\chi}^2=0.51$, p = 0.476) and GST-P1 (${\chi}^2=0.57$, p = 0.821) between the 2 groups. Comparison of the RLS score among genotypes of the GST-M1 (t = -1.54, p = 0.125), GST-T1 (t = -0.02, p = 0.985) and GST-P1 (F = 0.58, p = 0.560) revealed no significant difference. Conclusion: These data suggest that GST gene polymorphisms do not confer increased susceptibility to RLS symptoms in schizophrenic patients. Future studies are necessary to evaluate the possible influences of other candidate genes involved in the reactive oxygen species system.
Keywords
Restless legs syndrome; Antipsychotics; Schizophrenia; Glutathione S-transferase genes; Polymorphism;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003;4:101-119.   DOI   ScienceOn
2 Andreassen OA, Jorgensen HA. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol 2000;61:525-541.   DOI   ScienceOn
3 Baskol G, Korkmaz S, Erdem F, Caniklioglu A, Kocyigit M, Aksu M. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med 2012;13:414-418.   DOI   ScienceOn
4 Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for RLS on chromosome 9p. Am J Hum Genet 2004;74:876-889.   DOI   ScienceOn
5 Cho CH, Kang SG, Choi JE, Park YM, Lee HJ, Kim L. Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism. Psychiatry Investig 2009;6:211-215.   DOI   ScienceOn
6 Cikrikcioglu MA, Hursitoglu M, Erkal H, Kinas BE, Sztajzel J, Cakirca M, et al. Oxidative stress and autonomic nervous system functions in restless legs syndrome. Eur J Clin Invest 2011;41:734-742.   DOI   ScienceOn
7 de Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J Clin Psychopharmacol 2005;25:448-456.   DOI   ScienceOn
8 De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. The Lancet 1998;352:1986-1987.   DOI   ScienceOn
9 Desautels A, Turecki G, Montplaisir J, Ftouhi-Paquin N, Michaud M, Chouinard VA, et al. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology 2001;57:1304-1306.   DOI   ScienceOn
10 Desautels A, Turecki G, Montplaisir J, Xiong L, Walters AS, Ehrenberg BL, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 2005;62:591-596.   DOI   ScienceOn
11 Kang SG, Lee HJ, Choi JE, An H, Rhee M, Kim L. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia. Hum Psychopharmacol 2009;24:55-60.   DOI   ScienceOn
12 Han OS, Hong JP. Structured Clinical Interview for DSM-IV Axis I Disorder-Korean Version. Seoul, Hana Medical Publishing;2000.
13 Jung JS, Lee HJ, Cho CH, Kang SG, Yoon HK, Park YM, et al. Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. Chronobiol Int 2014;31:838-844.   DOI   ScienceOn
14 Kang SG, Lee HJ, Choi JE, Kim L, Jung IK. Association study between dopamine transporter gene 40 bp VNTR and antipsychotics-induced restless legs syndrome. Sleep Med Psychophysiol 2008;15:39-43.
15 Kang SG, Lee HJ, Choi JE, Park JH, Lee SS, Han C, et al. Possible association between G-protein ${\beta}3$ subunit C825T polymorphism and antipsychotic-induced restless legs syndrome in schizophrenia. Acta Neuropsychiatr 2007;19:351-356.   DOI   ScienceOn
16 Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, et al. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology 2008;57:49-54.   DOI   ScienceOn
17 Kang SG, Lee HJ, Jung SW, Cho SN, Han C, Kim YK, et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1078-1083.   DOI   ScienceOn
18 Kang SG, Lee HJ, Lee SH, Kim L. MEIS1, a Promising Candidate Gene, Is Not Associated with the Core Symptoms of Antipsychotic-Induced Restless Legs Syndrome in Korean Schizophrenia Patients. Psychiatry Investig 2015;12:263-267.   DOI   ScienceOn
19 Kang SG, Park YM, Choi JE, Lim SW, Lee HJ, Lee SH, et al. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol 2010;25:397-403.   DOI   ScienceOn
20 Kang SG, Lee HJ, Park YM, Yang HJ, Song HM, Lee YJ, et al. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. Hum Psychopharmacol 2013;28:117-123.   DOI   ScienceOn
21 Kemlink D, Plazzi G, Vetrugno R, Provini F, Polo O, Stiasny-Kolster K, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 2008;9:75-82.   DOI
22 Levchenko A, Montplaisir JY, Dube MP, Riviere JB, St-Onge J, Turecki G, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol 2004;55:887-891.   DOI   ScienceOn
23 Levchenko A, Provost S, Montplaisir JY, Xiong L, St-Onge J, Thibodeau P, et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology 2006;67:900-901.   DOI   ScienceOn
24 Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65.   DOI   ScienceOn
25 Ondo W, Jankovic J. Restless legs syndrome: Clinicoetiologic correlates. Neurology 1996;47:1435-1441.   DOI   ScienceOn
26 Pichler I, Marroni F, Volpato CB, Gusella JF, Klein C, Casari G, et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet 2006;79:716-723.   DOI   ScienceOn
27 Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W, et al. A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey. Neurology 1996;46:92-95.   DOI
28 Shen CP, Chou IC, Liu HP, Lee CC, Tsai Y, Wu BT, et al. Association of glutathione S-transferase P1 (GSTP1) polymorphism with Tourette syndrome in Taiwanese patients. Genet Test Mol Biomarkers 2014;18:41-44.   DOI   ScienceOn
29 Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix- Trench G. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001;22:67-72.   DOI   ScienceOn
30 Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:639-647.   DOI   ScienceOn
31 Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.   DOI   ScienceOn
32 Wang T, Wang B. Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: a meta-analysis. J Neurol Sci 2014;338:65-70.   DOI   ScienceOn
33 Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007;39:1000-1006.   DOI   ScienceOn
34 Zhong SL, Zhou SF, Chen X, Chan SY, Chan E, Ng KY, et al. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur J Pharm Sci 2006;28:77-85.   DOI   ScienceOn